Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 68,531
Sort by:

2019 Influenza A Virus H3N2 Subtype Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Influenza A Virus H3N2 Subtype Infections pipeline companies from advancing their products. Influenza A Virus H3N2 Subtype Infections Report Description The H1-2019 pipeline review report on Influenza A Virus H3N2 ... universities participating in the Influenza A Virus H3N2 Subtype Infections product pipeline are ...

March 2019 120 pages

2019 Influenza A Virus H5N1 Subtype Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Influenza A Virus H5N1 Subtype Infections pipeline companies from advancing their products. Influenza A Virus H5N1 Subtype Infections Report Description The H1-2019 pipeline review report on Influenza A Virus H5N1 ... universities participating in the Influenza A Virus H5N1 Subtype Infections product pipeline are ...

March 2019 130 pages

2019 Influenza A Virus, H7N9 Subtype Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Influenza A Virus, H7N9 Subtype Infections pipeline companies from advancing their products. Influenza A Virus, H7N9 Subtype Infections Report Description The H1-2019 pipeline review report on Influenza A Virus, H7N9 ... universities participating in the Influenza A Virus, H7N9 Subtype Infections product pipeline ...

March 2019 64 pages

2019 Influenza B virus Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Influenza B virus Infections pipeline companies from advancing their products. Influenza B virus Infections Report Description The H1-2019 pipeline review report on Influenza B virus Infections ... providers and universities participating in the Influenza B virus Infections product pipeline are provided. Company ...

March 2019 95 pages

2019 Iron Deficiency Anemia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... the Iron Deficiency Anemia pipeline companies from advancing their products. Iron Deficiency Anemia Report Description The H1-2019 pipeline review report on Iron Deficiency Anemia is ... license providers and universities participating in the Iron Deficiency Anemia product pipeline are provided. Company overview, ...

March 2019 56 pages

2019 Japanese Encephalitis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Japanese Encephalitis pipeline companies from advancing their products. Japanese Encephalitis Report Description The H1-2019 pipeline review report on Japanese Encephalitis is a comprehensive study on drug candidates ...

March 2019 40 pages

2019 Klebsiella pneumoniae Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Klebsiella pneumoniae Infections pipeline companies from advancing their products. Klebsiella pneumoniae Infections Report Description The H1-2019 pipeline review report on Klebsiella pneumoniae Infections ... and universities participating in the Klebsiella pneumoniae Infections product pipeline are provided. ...

March 2019 100 pages

2019 Lassa Fever (Lassa Hemorrhagic Fever) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Lassa Fever (Lassa Hemorrhagic Fever) pipeline companies from advancing their products. Lassa Fever (Lassa Hemorrhagic Fever) Report Description The H1-2019 pipeline review report on Lassa Fever (Lassa Hemorrhagic Fever) is a comprehensive study on drug ...

March 2019 53 pages

2019 Leishmaniasis (Kala-Azar) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Leishmaniasis (Kala-Azar) pipeline companies from advancing their products. Leishmaniasis (Kala-Azar) Report Description The H1-2019 pipeline review report on Leishmaniasis (Kala-Azar) is a comprehensive study on drug candidates ...

March 2019 100 pages

2019 Lyme Disease R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Lyme Disease pipeline companies from advancing their products. Lyme Disease Report Description The H1-2019 pipeline review report on Lyme Disease is a comprehensive study on drug candidates ...

March 2019 45 pages

2019 Marburgvirus Infections (Marburg Hemorrhagic Fever) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... some of the Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline companies from advancing their products. Marburgvirus Infections (Marburg Hemorrhagic Fever) Report Description The H1-2019 pipeline review report on Marburgvirus Infections (Marburg Hemorrhagic Fever) is a comprehensive ...

March 2019 55 pages

2019 Measles (rubeola) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Measles (rubeola) pipeline companies from advancing their products. Measles (rubeola) Report Description The H1-2019 pipeline review report on Measles (rubeola) is a comprehensive study on drug candidates ...

March 2019 40 pages

2019 Meningitis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Meningitis pipeline companies from advancing their products. Meningitis Report Description The H1-2019 pipeline review report on Meningitis is a comprehensive study on drug candidates across different ...

March 2019 30 pages

2019 Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... some of the Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections pipeline companies from advancing their products. Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections Report Description The H1-2019 pipeline review report on Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections ...

March 2019 40 pages

2019 Middle East Respiratory Syndrome (MERS) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... some of the Middle East Respiratory Syndrome (MERS) pipeline companies from advancing their products. Middle East Respiratory Syndrome (MERS) Report Description The H1-2019 pipeline review report on Middle East Respiratory Syndrome (MERS) is a comprehensive ...

March 2019 65 pages

2019 Mumps R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Mumps pipeline companies from advancing their products. Mumps Report Description The H1-2019 pipeline review report on Mumps is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Neisseria meningitidis Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Neisseria meningitidis Infections pipeline companies from advancing their products. Neisseria meningitidis Infections Report Description The H1-2019 pipeline review report on Neisseria meningitidis Infections ... and universities participating in the Neisseria meningitidis Infections product pipeline are provided. ...

March 2019 65 pages

2019 Neutropenia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Neutropenia pipeline companies from advancing their products. Neutropenia Report Description The H1-2019 pipeline review report on Neutropenia is a comprehensive study on drug candidates across different ...

March 2019 70 pages

2019 Onychomycosis (Nail fungus) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... the Onychomycosis (Nail fungus) pipeline companies from advancing their products. Onychomycosis (Nail fungus) Report Description The H1-2019 pipeline review report on Onychomycosis (Nail fungus) ... providers and universities participating in the Onychomycosis (Nail fungus) product pipeline are provided. Company ...

March 2019 55 pages

2019 Osteomyelitis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Osteomyelitis pipeline companies from advancing their products. Osteomyelitis Report Description The H1-2019 pipeline review report on Osteomyelitis is a comprehensive study on drug candidates across different ...

March 2019 34 pages

2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Paroxysmal Nocturnal Hemoglobinuria (PNH) pipeline companies from advancing their products. Paroxysmal Nocturnal Hemoglobinuria (PNH) Report Description The H1-2019 pipeline review report on Paroxysmal Nocturnal Hemoglobinuria (PNH) is a comprehensive study on drug ...

March 2019 65 pages

2019 Pertussis (Whooping Cough) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... the Pertussis (Whooping Cough) pipeline companies from advancing their products. Pertussis (Whooping Cough) Report Description The H1-2019 pipeline review report on Pertussis (Whooping Cough) ... providers and universities participating in the Pertussis (Whooping Cough) product pipeline are provided. Company ...

March 2019 72 pages

2019 Plague R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Plague pipeline companies from advancing their products. Plague Report Description The H1-2019 pipeline review report on Plague is a comprehensive study on drug candidates across different ...

March 2019 45 pages

2019 Poliomyelitis (Polio) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Poliomyelitis (Polio) pipeline companies from advancing their products. Poliomyelitis (Polio) Report Description The H1-2019 pipeline review report on Poliomyelitis (Polio) is a comprehensive study on drug candidates ...

March 2019 66 pages

2019 Progressive Multifocal Leukoencephalopathy R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Progressive Multifocal Leukoencephalopathy pipeline companies from advancing their products. Progressive Multifocal Leukoencephalopathy Report Description The H1-2019 pipeline review report on Progressive Multifocal Leukoencephalopathy is a comprehensive study on drug ...

March 2019 40 pages

2019 Pseudomonas aeruginosa Pneumonia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Pseudomonas aeruginosa Pneumonia pipeline companies from advancing their products. Pseudomonas aeruginosa Pneumonia Report Description The H1-2019 pipeline review report on Pseudomonas aeruginosa Pneumonia ... and universities participating in the Pseudomonas aeruginosa Pneumonia product pipeline are provided. ...

March 2019 35 pages

2019 Pyelonephritis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Pyelonephritis pipeline companies from advancing their products. Pyelonephritis Report Description The H1-2019 pipeline review report on Pyelonephritis is a comprehensive study on drug candidates across different ...

March 2019 55 pages

2019 Q Fever R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Q Fever pipeline companies from advancing their products. Q Fever Report Description The H1-2019 pipeline review report on Q Fever is a comprehensive study on drug candidates ...

March 2019 24 pages

2019 Rabies R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Rabies pipeline companies from advancing their products. Rabies Report Description The H1-2019 pipeline review report on Rabies is a comprehensive study on drug candidates across different ...

March 2019 60 pages

2019 Resistant Pseudomonas aeruginosa Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Resistant Pseudomonas aeruginosa Infections pipeline companies from advancing their products. Resistant Pseudomonas aeruginosa Infections Report Description The H1-2019 pipeline review report on Resistant Pseudomonas aeruginosa Infections is a comprehensive study on drug ...

March 2019 55 pages

2019 Rhinovirus Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Rhinovirus Infections pipeline companies from advancing their products. Rhinovirus Infections Report Description The H1-2019 pipeline review report on Rhinovirus Infections is a comprehensive study on drug candidates ...

March 2019 51 pages

2019 Rotavirus Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Rotavirus Infections pipeline companies from advancing their products. Rotavirus Infections Report Description The H1-2019 pipeline review report on Rotavirus Infections is a comprehensive study on drug candidates ...

March 2019 50 pages

2019 Rubella (German Measles) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... the Rubella (German Measles) pipeline companies from advancing their products. Rubella (German Measles) Report Description The H1-2019 pipeline review report on Rubella (German Measles) is ... license providers and universities participating in the Rubella (German Measles) product pipeline are provided. Company ...

March 2019 40 pages

2019 Schistosomiasis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Schistosomiasis pipeline companies from advancing their products. Schistosomiasis Report Description The H1-2019 pipeline review report on Schistosomiasis is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Severe Acute Respiratory Syndrome (SARS) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... some of the Severe Acute Respiratory Syndrome (SARS) pipeline companies from advancing their products. Severe Acute Respiratory Syndrome (SARS) Report Description The H1-2019 pipeline review report on Severe Acute Respiratory Syndrome (SARS) is a comprehensive ...

March 2019 65 pages

2019 Smallpox R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Smallpox pipeline companies from advancing their products. Smallpox Report Description The H1-2019 pipeline review report on Smallpox is a comprehensive study on drug candidates across different ...

March 2019 50 pages

2019 Streptococcus pyogenes Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Streptococcus pyogenes Infections pipeline companies from advancing their products. Streptococcus pyogenes Infections Report Description The H1-2019 pipeline review report on Streptococcus pyogenes Infections ... and universities participating in the Streptococcus pyogenes Infections product pipeline are provided. ...

March 2019 45 pages

2019 Tetanus R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Tetanus pipeline companies from advancing their products. Tetanus Report Description The H1-2019 pipeline review report on Tetanus is a comprehensive study on drug candidates across different ...

March 2019 65 pages

2019 Thalassemia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Thalassemia pipeline companies from advancing their products. Thalassemia Report Description The H1-2019 pipeline review report on Thalassemia is a comprehensive study on drug candidates across different ...

March 2019 120 pages

2019 Thrombotic Thrombocytopenic Purpura (Moschcowitz syndrome) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... of the Thrombotic Thrombocytopenic Purpura (Moschcowitz syndrome) pipeline companies from advancing their products. Thrombotic Thrombocytopenic Purpura (Moschcowitz syndrome) Report Description The H1-2019 pipeline review report on Thrombotic Thrombocytopenic Purpura (Moschcowitz syndrome) is a comprehensive ...

March 2019 30 pages

2019 Tinea pedis (Athlete Foot) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Tinea pedis (Athlete Foot) pipeline companies from advancing their products. Tinea pedis (Athlete Foot) Report Description The H1-2019 pipeline review report on Tinea pedis (Athlete Foot) is a comprehensive study on drug ...

March 2019 40 pages

2019 Toxoplasmosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Toxoplasmosis pipeline companies from advancing their products. Toxoplasmosis Report Description The H1-2019 pipeline review report on Toxoplasmosis is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Tularaemia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Tularaemia pipeline companies from advancing their products. Tularaemia Report Description The H1-2019 pipeline review report on Tularaemia is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Typhoid Fever R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Typhoid Fever pipeline companies from advancing their products. Typhoid Fever Report Description The H1-2019 pipeline review report on Typhoid Fever is a comprehensive study on drug candidates ...

March 2019 45 pages

2019 Vancomycin-Resistant Enterococcus faecium Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Vancomycin-Resistant Enterococcus faecium Infections pipeline companies from advancing their products. Vancomycin-Resistant Enterococcus faecium Infections Report Description The H1-2019 pipeline review report on Vancomycin-Resistant Enterococcus faecium Infections is a comprehensive study ...

March 2019 69 pages

2019 Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections pipeline companies from advancing their products. Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Report Description The H1-2019 pipeline review report on Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections ...

March 2019 45 pages

2019 Ventilator Associated Pneumonia (VAP) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Ventilator Associated Pneumonia (VAP) pipeline companies from advancing their products. Ventilator Associated Pneumonia (VAP) Report Description The H1-2019 pipeline review report on Ventilator Associated Pneumonia (VAP) is a comprehensive study on drug ...

March 2019 75 pages

2019 Warts R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Warts pipeline companies from advancing their products. Warts Report Description The H1-2019 pipeline review report on Warts is a comprehensive study on drug candidates across different ...

March 2019 75 pages

2019 West Nile Virus Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the West Nile Virus Infections pipeline companies from advancing their products. West Nile Virus Infections Report Description The H1-2019 pipeline review report on West Nile Virus Infections is a comprehensive study on drug ...

March 2019 50 pages

2019 Western Equine Encephalitis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Western Equine Encephalitis pipeline companies from advancing their products. Western Equine Encephalitis Report Description The H1-2019 pipeline review report on Western Equine Encephalitis ... providers and universities participating in the Western Equine Encephalitis product pipeline are provided. Company ...

March 2019 35 pages

Filters

Search

Categories

186
1,003
31
222
180
154
139
126
63,609
1,041
751
929
160

Publishers

179
1
239
347
389
103
826
148
348
3
202
3
6
1,620
487
76
123
208
111
25
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,207
4,664
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
354
8
3
18
58
906
6
89
12
24
15
1,285
227
128
386
3
74
10
119
230
46
474
26
133
4

Regions

89
58
45
41
41
35
31
30
30
29
28
28
28
26
21
18
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
795
495
2
2
2
117
195
102
53
23
704
26
134
526
174
627
63,501

Price

Date

Pages

Offers

1
280
1
1